Aclidinium bromide
Aclidinium bromide is a long-acting, inhaled muscarinic antagonist approved in the US on July 24, 2012 as a maintenance treatment for chronic obstructive pulmonary disease. Evidence shows that it can improve quality of life and prevent hospitalization in those with COPD.
Aclidinium Bromide People (First 3 people) - Page 0
4-DAMP
AFDX-384
Drug